Early research (Phase 1)Study completedNCT01469052What this trial is testingFirst In Human, Phase 1 Study of AG013736 In Patients With Solid TumorsWho this might be right forAdvanced Solid Tumors Pfizer 36
Testing effectiveness (Phase 2)WithdrawnNCT02747797What this trial is testingLucitanib (E3810) in Patients With Advanced Cancer and FGFR, VEGFR, or PDGFR Pathway AberrationsWho this might be right forAdvanced Cancer Teresa Helsten, MD
Testing effectiveness (Phase 2)Ended earlyNCT00445549What this trial is testingVandetanib to Treat Women With Ovarian, Fallopian Tube, or Primary Peritoneal CancerWho this might be right forOvarian NeoplasmsFallopian Tube NeoplasmsPeritoneal Neoplasms National Cancer Institute (NCI) 12
Early research (Phase 1)Study completedNCT04393506What this trial is testingInductive Camrelizumab and Apatinib for Patients With Locally Advanced and Resectable Oral Squamous Cell CarcinomaWho this might be right forOral CancerVEGFR2 InhibitorProgrammed Cell Death 1 Inhibitor+1 more Shanghai Jiao Tong University School of Medicine 21
Testing effectiveness (Phase 2)Ended earlyNCT00402896What this trial is testingMalignant Pleural Effusion With ZD6474Who this might be right forLung CancerPleural Effusion M.D. Anderson Cancer Center 28
Large-scale testing (Phase 3)Looking for participantsNCT05691478What this trial is testingTest the Addition of the Drug Cabozantinib to Chemotherapy in Patients With Newly Diagnosed OsteosarcomaWho this might be right forHigh Grade OsteosarcomaLocalized OsteosarcomaMetastatic Osteosarcoma+1 more National Cancer Institute (NCI) 1,122
Testing effectiveness (Phase 2)Study completedNCT00725764What this trial is testingPhase 2 Study of GSK1363089 (Formerly XL880) in Adults With Squamous Cell Cancer of the Head and NeckWho this might be right forNeoplasms, Head and Neck GlaxoSmithKline 14
Large-scale testing (Phase 3)Study completedNCT01865747What this trial is testingCabozantinib (XL184) vs Everolimus in Subjects With Metastatic Renal Cell CarcinomaWho this might be right forRenal Cell Carcinoma Exelixis 658
Testing effectiveness (Phase 2)Ended earlyNCT06006923What this trial is testingRegorafenib in Combination With Pembrolizumab or Pembrolizumab for MSI-H Colorectal CancerWho this might be right forMSI-H Colorectal Cancer Anwaar Saeed 1
Testing effectiveness (Phase 2)Looking for participantsNCT04072042What this trial is testingBIOmarker Driven Trial of VEGFR2 Inhibitor in Advanced or Metastatic SarcomaWho this might be right forSarcoma Ruijin Hospital 30
Testing effectiveness (Phase 2)Active Not RecruitingNCT06116890What this trial is testingStudy to Assess the Efficacy & Safety of KHK4951 in Patients With Neovascular Age-Related Macular DegenerationWho this might be right forNeovascular Age-Related Macular Degeneration (nAMD) Kyowa Kirin Co., Ltd. 180
Testing effectiveness (Phase 2)Study completedNCT01068587What this trial is testingMET/VEGFR2 Inhibitor GSK1363089 and Erlotinib Hydrochloride or Erlotinib Hydrochloride Alone in Locally Advanced or Metastatic NSCLC That Has Not Responded to Previous ChemotherapyWho this might be right forLung Cancer NCIC Clinical Trials Group 31
Testing effectiveness (Phase 2)Study completedNCT00117299What this trial is testingPTK787/ZK222584 in the Treatment of Metastatic Gastrointestinal Stromal Tumors Resistant to ImatinibWho this might be right forSarcoma University of Helsinki 45
Early research (Phase 1)Study completedNCT00426452What this trial is testingA Drug-drug Interaction Study of Oral 1250 mg of Vatalinib Administered Under Fasting and Fed Conditions With a Proton-pump Inhibitor in Healthy Sterile or Postmenopausal Female VolunteersWho this might be right forHealthy Novartis 24
Early research (Phase 1)Study completedNCT00321581What this trial is testingAZD2171 to Treat Children and Adolescents With Solid Tumors or Acute Myelogenous LeukemiaWho this might be right forRefractory or Recurrent Solid TumorsAcute Myelogenous Leukemia National Cancer Institute (NCI) 18
Testing effectiveness (Phase 2)Active Not RecruitingNCT06116916What this trial is testingStudy to Assess the Efficacy & Safety of KHK4951 in Patients With Diabetic Macular EdemaWho this might be right forDiabetic Macular Edema (DME) Kyowa Kirin Co., Ltd. 150
Early research (Phase 1)Ended earlyNCT00450879What this trial is testingPazopanib in Treating Patients With Newly Diagnosed or Locally and/or Regionally Recurrent Breast Cancer That Can Be Removed By SurgeryWho this might be right forMale Breast CarcinomaRecurrent Breast CarcinomaStage IA Breast Cancer+4 more National Cancer Institute (NCI) 19
Large-scale testing (Phase 3)Study completedNCT01908426What this trial is testingStudy of Cabozantinib (XL184) vs Placebo in Subjects With Hepatocellular Carcinoma Who Have Received Prior SorafenibWho this might be right forHepatocellular Carcinoma Exelixis 707
Testing effectiveness (Phase 2)Looking for participantsNCT07049926What this trial is testingSubstudy 03C: A Study of Combination Therapies in Participants With Renal Cell Carcinoma With Recurrent Disease During or After Anti-PD-(L)1 Therapy (MK-3475-03C/KEYMAKER-U03)Who this might be right forRenal Cell Carcinoma Merck Sharp & Dohme LLC 140
Testing effectiveness (Phase 2)Looking for participantsNCT04645160What this trial is testingEvaluating Efficacy of Tivozanib (AV-951) in Biliary Tract CancersWho this might be right forCholangiocarcinomaBile Duct NeoplasmBiliary Tract Malignancy National Cancer Institute (NCI) 31